Efficacy and safety trial of AJG555 in patients with chronic constipation (Phase 3 study)
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2017
At a glance
- Drugs AJG 555 (Primary)
- Indications Constipation
- Focus Registrational; Therapeutic Use
- Sponsors Ajinomoto Pharma; EA Pharma
- 05 Oct 2017 Status changed from active, no longer recruiting to completed.
- 02 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 13 Jun 2016 New trial record